Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Palliative Sedation in Patients With Terminal Illness

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Book

Palliative Sedation in Patients With Terminal Illness

Poonam Bhyan et al.

Excerpt

Palliative sedation encompasses a broad range of activities aimed at relieving distress in terminally ill patients. Palliative sedation involves therapy to resolve or alleviate refractory symptoms at the end of life. The most common refractory symptoms in terminally ill patients are delirium, intractable pain, and shortness of breath. There is a well-established practice and relative acceptance of the use of palliative sedation to relieve these symptoms. However, there is still open controversy and ethical debate about the use of palliative sedation for the relief of existential or psychological distress in terminally ill patients.

Some controversy arises over a lack of consistency in defining "refractory symptoms" and a lack of adequate knowledge among patients, family members, and healthcare workers alike regarding the issue of palliative sedation. Additionally, ethical and legal issues surrounding this topic, as it appears, at least superficially similar to the process of physician-assisted suicide or euthanasia, discourage physicians from initiating conversations or planning for palliative sedation in patients. For clarity, the goal of palliative sedation is truly aimed at sedation, not a cessation of life, and studies have shown that palliative sedation overall is not associated with a shortened life span. Also, one of the guiding principles of palliative sedation is that it is applied when the anticipated life span of a terminally ill patient is in the range of hours to days.

Prior studies have demonstrated several communication barriers between clinicians, patients, and surrogates that prevent timely planning for end-of-life issues, leading to increased anxiety and frustrations towards the medical team. Furthermore, several misconceptions remain among patients and their families regarding palliative care issues, including hospice, pain control, and palliative sedation. This review discusses the indications for palliative sedation, legal/ethical dynamics associated with its use, common misconceptions, and pharmacological agents used.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Poonam Bhyan declares no relevant financial relationships with ineligible companies.

Disclosure: Utsav Shrestha declares no relevant financial relationships with ineligible companies.

Disclosure: Caroline Schoo declares no relevant financial relationships with ineligible companies.

Disclosure: Amandeep Goyal declares no relevant financial relationships with ineligible companies.

References

    1. Sulmasy DP. Sedation and care at the end of life. Theor Med Bioeth. 2018 Jun;39(3):171-180. - PubMed
    1. Bobb B. A Review of Palliative Sedation. Nurs Clin North Am. 2016 Sep;51(3):449-57. - PubMed
    1. Patel C, Kleinig P, Bakker M, Tait P. Palliative sedation: A safety net for the relief of refractory and intolerable symptoms at the end of life. Aust J Gen Pract. 2019 Dec;48(12):838-845. - PubMed
    1. Garetto F, Cancelli F, Rossi R, Maltoni M. Palliative Sedation for the Terminally Ill Patient. CNS Drugs. 2018 Oct;32(10):951-961. - PubMed
    1. Maltoni M, Scarpi E, Rosati M, Derni S, Fabbri L, Martini F, Amadori D, Nanni O. Palliative sedation in end-of-life care and survival: a systematic review. J Clin Oncol. 2012 Apr 20;30(12):1378-83. - PubMed

Publication types